# Takahiro Osawa

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/takahiro-osawa/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,806 |
| Field | Bladder and Urothelial Cancer Treatments |
| h-index | 26 |
| i10-index | 62 |
| Last Known Institution | Hokkaido University |
| OpenAlex ID | https://openalex.org/A5073146256 |
| ORCID iD | 0000-0003-4444-7958 |
| Works | 229 |

## Researcher papers

Showing 12 of 14.

- [Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial](https://scholariq.org/papers/atezolizumab-plus-cabozantinib-versus-cabozantinib-monotherapy-for-patients-with/)
- [Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial](https://scholariq.org/papers/ramucirumab-plus-docetaxel-versus-placebo-plus-docetaxel-in-patients-with/)
- [Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study](https://scholariq.org/papers/lenvatinib-plus-pembrolizumab-versus-sunitinib-in-first-line-treatment-of/)
- [Heterogeneity of Tumor Endothelial Cells](https://scholariq.org/papers/heterogeneity-of-tumor-endothelial-cells/)
- [Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells](https://scholariq.org/papers/biglycan-is-a-specific-marker-and-an-autocrine-angiogenic-factor-of-tumour/)
- [Tumor-Derived Microvesicles Induce Proangiogenic Phenotype in Endothelial Cells via Endocytosis](https://scholariq.org/papers/tumor-derived-microvesicles-induce-proangiogenic-phenotype-in-endothelial-cells/)
- [Impact of Diagnostic Ureteroscopy on Intravesical Recurrence and Survival in Patients With Urothelial Carcinoma of the Upper Urinary Tract](https://scholariq.org/papers/impact-of-diagnostic-ureteroscopy-on-intravesical-recurrence-and-survival-in/)
- [Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial](https://scholariq.org/papers/ramucirumab-plus-docetaxel-versus-placebo-plus-docetaxel-in-patients-with-2/)
- [Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis](https://scholariq.org/papers/lysyl-oxidase-secreted-by-tumour-endothelial-cells-promotes-angiogenesis-and/)
- [CXCR7: A novel tumor endothelial marker in renal cell carcinoma](https://scholariq.org/papers/cxcr7-a-novel-tumor-endothelial-marker-in-renal-cell-carcinoma/)
- [Motion analysis for better understanding of psychomotor skills in laparoscopy: objective assessment-based simulation training using animal organs](https://scholariq.org/papers/motion-analysis-for-better-understanding-of-psychomotor-skills-in-laparoscopy/)
- [Automatic assessment of laparoscopic surgical skill competence based on motion metrics](https://scholariq.org/papers/automatic-assessment-of-laparoscopic-surgical-skill-competence-based-on-motion/)

## Researcher topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Urinary and Genital Oncology Studies](https://scholariq.org/topics/urinary-and-genital-oncology-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Multiple and Secondary Primary Cancers](https://scholariq.org/topics/multiple-and-secondary-primary-cancers/)

## Researcher university

- [Hokkaido University](https://scholariq.org/institutions/hokkaido-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.